Antithrombotic Therapy in Stroke Prevention and Treatment: A Review

被引：0
作者：
Marilyn M. Rymer
机构：
[1] Saint Luke's Hospital Stroke Center,
来源：
Journal of Thrombosis and Thrombolysis | 1998年 / 5卷 / Suppl 1期
关键词：
anticoagulant; stroke; tPA; atrial fibrillation;
D O I：
10.1023/A:1013289004656
中图分类号：
学科分类号：
摘要：
Current knowledge of antithrombotic therapy based on controlled clinical trials has revolutionized the way clinicians approach stroke prevention and treatment. This review article addresses the pathogenesis of stroke and summarizes information from clinical trials regarding the use of antiplatelet agents, heparin, warfarin (particularly in nonvalvular atrial fibrillation), and thrombolytics in stroke prevention and treatment.
引用
收藏
页码：43 / 47
页数：4
相关论文
共 29 条
  • [1] Matcher DB(1994)Medical treatment for stroke prevention Ann Intern Med 121 41-53
  • [2] McCrory DC(1996)Primary care physician-reported secondary and tertiary stroke prevention practices Stroke 27 1472-1478
  • [3] Barnett HJM(1995)Primary prevention of stroke N Eng J Med 333 1392-1400
  • [4] Feussner JR.(1995)Drugs and surgery in the prevention of ischemic stroke N Eng Med 332 238-248
  • [5] Goldstein LB(1988)A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients N Eng J Med 321 501-507
  • [6] Farmer A(1989)The Canadian American Ticlopidine Study (CATS) in thromboembolic storke Lancet 1 1215-1220
  • [7] Matcher DB.(1997)Ventricular dysfunction and risk of stroke after myocardial infarction N Eng Med 336 251-257
  • [8] Bronner LL(1991)Stroke Prevention in Atrial Fibrillation Study: Final results Circulation 84 527-539
  • [9] Kanter DS(1994)Warfarin vs. ASA for prevention of thromboembolism in atrial fibrillation Lancet 343 687-691
  • [10] Manson JE.(1995)Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia N Eng Med 333 5-10
123